Mironova Labs

DMTMM for Aqueous Bioconjugation

Outperforms EDC/NHS in water — no persistent residues, no pre-activation

For bioconjugation and ADC scientists working with carboxyl-amine coupling in aqueous buffers

Request Evaluation Kit DMTMM Science Hub

≥99%

Purity (HPLC)

~$12B

ADC Market (2024)

pH 4–8

Aqueous Range

No HOBt

Safer Chemistry

Supported by peer-reviewed research·≥99% purity (HPLC)·Water-soluble reagent & byproducts·US-manufactured·Published comparisons vs EDC/NHS

DMTMM·Cl activates carboxylic acids directly in aqueous buffers at pH 4–8 without organic co-solvents or the multi-step EDC/NHS protocol. Published comparisons show higher conjugation efficiency on hyaluronan substrates, and byproducts are water-soluble and removable — unlike persistent EDC residues.

DMTMM Science Hub Coupling Reagent Catalog

Challenges & Solutions

Your Challenge. Our Answer.

We understand the specific problems you face — and we built solutions for each one.

The Problem

EDC/NHS requires tight pH control (optimal 3.5–4.5) and pre-activation timing — a reproducibility nightmare at scale

Mironova’s Answer

DMTMM·Cl activates carboxylic acids directly in water at pH 6–8 by simple mixing. No pre-activation step, no pH shifts required.

The Problem

EDC conjugation yields are often <20% for polysaccharide-protein vaccine conjugates at manufacturing scale

Mironova’s Answer

DMTMM produced higher degrees of substitution than EDC/NHS across all tested substrate classes in systematic comparisons

The Problem

EDC/NHS leaves persistent N-acylurea residues on surfaces that cannot be removed even after repeated washing

Mironova’s Answer

DMTMM produces water-soluble byproducts (2-hydroxy-4,6-dimethoxy-triazine) — clean surfaces, simple dialysis cleanup

Published Research

Published Evidence

Key findings from peer-reviewed literature relevant to your application.

Superior Substitution vs EDC/NHS

DMTMM yielded superior degrees of substitution vs EDC/NHS across all tested substrates at matched feed ratios, without requiring pH control.

D’Este et al., Carbohydrate Polymers 2014

Persistent EDC Residues

EDC/NHS left persistent N-acylurea byproducts on CNF surfaces that could not be removed even after repeated washing and dialysis. DMTMM avoided this.

Kumar et al., Communications Chemistry 2023

Low EDC Conjugation Yields

In EDC-based vaccine conjugate manufacturing, "considerably less than 20% of the activated PS becomes conjugated."

Frasch, Vaccine 2009

Market Context

Antibody-Drug Conjugates Are Driving Bioconjugation Demand

The ADC market is estimated at over $12B (2024) and projected to exceed $30B by 2033. As bioconjugation moves to larger scales and GMP environments, reagent choice directly impacts process reproducibility, purification burden, and regulatory documentation. Aqueous-compatible coupling without tight pH choreography is a practical advantage at manufacturing scale.

Grand View Research; Roots Analysis; Mironova analysis

>$30B

Projected ADC market by 2033

80%

Less impurity at 99% vs 95% (calculated)

Product Catalog

Aqueous Bioconjugation Protocol

Water, phosphate buffer, or MES buffer (pH 6–8).

Equivalents: 1.0–5.0 eq relative to carboxyl groups.

Temperature: RT to 37 °C. Time: 1–24 h (substrate-dependent).

No pre-activation step — add DMTMM·Cl directly to reaction mixture.

For full protocols and peer-reviewed studies, please visit our DMTMM Science Hub.

Why Mironova

Your Advantage with Mironova

Aqueous-Native Activation

DMTMM·Cl is freely water-soluble and activates carboxylic acids directly in aqueous buffers at pH 4–8 without organic co-solvents or EDC/NHS pH-shift protocols.

Higher Conjugation Efficiency

Published comparison with hyaluronan shows higher degree of substitution at matched feed ratios vs EDC/NHS, without tight pH control requirements (D’Este et al., Carbohydr. Polym. 2014).

No EDC Residue Risk

EDC/NHS can leave persistent N-acylurea-type residues on certain substrates that are not removed by washing or dialysis. DMTMM byproducts are water-soluble and removable.

99%+ Purity for Process Consistency

Higher reagent purity reduces batch-to-batch variability in conjugation efficiency — critical for GMP bioconjugation manufacturing.

Request Technical Data

Get product specifications, CoA samples, and pricing for your evaluation.

FAQ

Frequently Asked Questions

Common technical questions about this product line, answered by our scientific team.

The primary triazine byproduct is water-soluble and typically removable by dialysis or gel filtration. However, the triazine can covalently attach to phenolic residues (e.g., tyrosine, tyramine) forming stable Tyr-O-DMT adducts (Golunova et al., Int. J. Mol. Sci. 2021). If your substrate contains accessible phenols, test for this side reaction.

Yes — DMTMM can form adducts with xanthene dyes (ACS Omega 2022). If your bioconjugation involves fluorescent labeling, validate compatibility or adjust the order of operations.

DMTMM activates carboxylic acids to form acyloxytriazine intermediates that react directly with amines. No sulfo-NHS ester intermediate is needed. This simplifies the protocol and avoids the EDC half-life limitation (~3.9 h at pH 5.0, 25°C).

DMTMM is a chemical reagent, not a GMP-certified product. However, our 99%+ purity with full CoA documentation (HPLC, NMR, MS) provides a starting point for your GMP qualification process. Contact us for detailed analytical packages.